CYIG's Research Advances Through the Cooperation With NFU
July 22 2014 - 8:00AM
China YCT International Group, Inc (OTC:CYIG) has recently held a
work conference with Nanjing Forestry University (NFU). The two
sides had in-depth communications about the company development and
the future of acer truncatum as well as the cooperation plan.
Cao Fu Liang, Principal of the NFU stated at the conference that
after several years cooperation with CYIG, both have achieved a lot
of scientific goals in gingko research and production. During this
time, CYIG took on some governmental programs including the
national Torch Program, the Provincial and National Enriching
People and County programs and were awarded a second place in the
China national scientific progress prize.
As a high-tech enterprise, the Company built a technologically
innovative platform consisting of provincial engineering technology
research center and the preparation engineering laboratory. The
researchers in the Center consist of more than 20 professionals and
many other engineers of which 60% of them are senior level. The
Center is equipped with provincial standardized experimental
facilities and is thus suited to national and provincial research
plans and tests, and sets down products techniques and processes
for the Company. The Center holds 4 national invention patents.
The Laboratory contains 2 workshops. The natural medicine
extraction shop is responsible for extracting, isolating and
purifying the functional ingredients from the gingko aglycone
flavonoids and acer truncatum at the same time. The shop can also
deal with a hundred more Chinese medical herbs extraction and
purification.
Based on downstream products of gingko and acer truncatum, the
biological feed shop adopted biological fermentation and enzyme
technology to produce antibiotic-free additives which could replace
the antibiotic additives has now being widely used in cultivation
industry.
Mr. Tinghe Yan,The CEO of CYIG commented that, "CYIG has grown
up as time goes by and now became a famous China pharmaceutical
company with rapid growth. Adhere to the enterprise purpose of
'casting quality and building the brand in the future, CYIG is
stepping onto the worldwide stage and embracing the new period of
fast development."
With the development of our society and the evolvement of the
human being, health has became the most concerned thing. CYIG views
the public healthcare as its duty and therefore helps people by
their various kind of medicine products to make a better society
and world.
The Strategy leads the development and innovation drives the
progress. Under the Five Years Development Plan of CYIG, the
company implements the strategy for the project to rapidly expand
the business scale and market share. We will carry forward the
company's advanced culture, strive to explore a new business model,
commit to the enterprise long-term value creation, and provide
consumers good quality and efficient products and services.
Meanwhile, we will actively fulfill the social responsibility,
return our shareholders, customers, society and employees with
fruitful results from the development of enterprise, realize the
aim of 'the pursuit of profits'".
For more information, visit www.yctgroup.com
Safe Harbor Statement
Certain statements in this press release, constitute
forward-looking statements for purposes of the safe harbor
provisions under The Private Securities Litigation Reform Act of
1995. These statements include, without limitation, statements
regarding the Company's future performance. The Company has based
these forward-looking statements largely on its current
expectations and projections about future events and financial
trends that we believe may affect our financial condition, results
of operations, business strategy and financial needs. Although the
Company believes that the expectations reflected in these
forward-looking statements are reasonable, they do involve
assumptions, risks and uncertainties, and these expectations may
prove to be incorrect. Investors should not place undue reliance on
these forward-looking statements, which speak only as of the date
of this press release. The Company's actual results could differ
materially from those anticipated in these forward-looking
statements as a result of a variety of factors, including those
discussed in the periodic reports that are filed with the
Securities and Exchange Commission. All forward-looking statements
attributable to the Company or persons acting on its behalf are
expressly qualified in their entirety by these factors. The Company
undertakes no duty to update these forward-looking statements
except as required by law.
CONTACT: Zecheng Shao
Tel: 0086-537-4268276
Email: zecheng.shao@gmail.com